Skip to content

Inflammatory Bowel Disease and Atherosclerosis Development

Inflammatory Bowel Disease and Atherosclerosis Development

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05781737
Enrollment
115
Registered
2023-03-23
Start date
2022-11-01
Completion date
2025-01-30
Last updated
2026-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial Stiffness, Cardiovascular Diseases, Inflammation, Inflammatory Bowel Diseases

Brief summary

The study will show the influence of inflammatory bowel disease on the risk of development of atherosclerosis

Interventions

None listed

Sponsors

I.M. Sechenov First Moscow State Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Inflammatory bowel disease * Signed informed consent

Exclusion criteria

* Pregnancy * Other conditions affecting the prognosis * Psychiatric disorders affecting the participation in the study

Design outcomes

Primary

MeasureTime frameDescription
Intima-media thickness1 yearIntima-media thickness
Pulse wave velocity1 yearPulse wave velocity

Secondary

MeasureTime frame
All cause mortality1 year
Cardiovascular mortality1 year
Hospitalisation due to cardiovascular disease1 year

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 13, 2026